Keith Michael Gottesdiener, CEO and President at RHYTHM PHARMACEUTICALS, INC. (RYTM), sold 4,263 shares at $30.01 ($128K) on 2019-02-27, disclosed to the SEC on 2019-02-28.
Open-market sale of $128k RYTM by CEO and President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.13 | 635 | $19K | 14.9% |
| 2 | $30.01 | 1,814 | $54K | 42.5% |
| 3 | $30.01 | 1,814 | $54K | 42.5% |
| Total | $30.03 avg | 4,263 | $128K | 100% |
| Filing → |
| RYTM | SELL | 2019-02-20 | $748K | — | Filing → |
| RYTM | SELL | 2019-02-15 | $118K | — | Filing → |
| RYTM | SELL | 2019-01-24 | $945K | — | Filing → |